Machine Learning Strategies When Transitioning between Biological Assays.


Journal

Journal of chemical information and modeling
ISSN: 1549-960X
Titre abrégé: J Chem Inf Model
Pays: United States
ID NLM: 101230060

Informations de publication

Date de publication:
26 07 2021
Historique:
pubmed: 22 6 2021
medline: 10 8 2021
entrez: 21 6 2021
Statut: ppublish

Résumé

Machine learning is widely used in drug development to predict activity in biological assays based on chemical structure. However, the process of transitioning from one experimental setup to another for the same biological endpoint has not been extensively studied. In a retrospective study, we here explore different modeling strategies of how to combine data from the old and new assays when training conformal prediction models using data from hERG and Na

Identifiants

pubmed: 34152755
doi: 10.1021/acs.jcim.1c00293
pmc: PMC8317157
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

3722-3733

Références

Expert Opin Drug Metab Toxicol. 2006 Dec;2(6):823-33
pubmed: 17125403
Front Pharmacol. 2018 Nov 06;9:1256
pubmed: 30459617
J Chem Inf Model. 2014 Oct 27;54(10):2647-53
pubmed: 25230336
J Biomol Screen. 2003 Feb;8(1):50-64
pubmed: 12854998
J Pharmacol Toxicol Methods. 2006 Sep-Oct;54(2):189-99
pubmed: 16563806
J Cheminform. 2018 Apr 3;10(1):17
pubmed: 29616425
Br J Pharmacol. 2011 Mar;162(6):1239-49
pubmed: 21091654
Curr Opin Drug Discov Devel. 2001 Jan;4(1):110-5
pubmed: 11727316
Trends Pharmacol Sci. 2019 Sep;40(9):624-635
pubmed: 31383376
SAR QSAR Environ Res. 2019 Apr;30(4):265-277
pubmed: 31012353
J Chem Inf Model. 2017 Jul 24;57(7):1591-1598
pubmed: 28628322
J Cheminform. 2021 Apr 29;13(1):35
pubmed: 33926567
J Chem Inf Model. 2014 Nov 24;54(11):3211-7
pubmed: 25318024
Front Pharmacol. 2011 Dec 13;2:78
pubmed: 22171219
Lancet. 1986 Feb 8;1(8476):307-10
pubmed: 2868172
J Pharm Sci. 2021 Jan;110(1):42-49
pubmed: 33075380
Mol Divers. 2010 Nov;14(4):687-96
pubmed: 19921452
Lancet. 1999 Nov 6;354(9190):1625-33
pubmed: 10560690
J Cheminform. 2017 Mar 7;9:17
pubmed: 28316655
Neural Netw. 2011 Oct;24(8):842-51
pubmed: 21719251
J Cheminform. 2016 Aug 10;8:39
pubmed: 27516811
J Chem Inf Comput Sci. 2003 May-Jun;43(3):721-34
pubmed: 12767130
Biomolecules. 2018 Aug 29;8(3):
pubmed: 30158463
Methods Mol Biol. 2013;930:341-54
pubmed: 23086849
J Mol Graph Model. 2017 Mar;72:256-265
pubmed: 28135672
Toxicol Appl Pharmacol. 2009 Dec 15;241(3):356-70
pubmed: 19716836
Nucleic Acids Res. 2019 Jan 8;47(D1):D930-D940
pubmed: 30398643
Front Pharmacol. 2014 Sep 02;5:203
pubmed: 25228880
Mutagenesis. 2019 Mar 6;34(1):33-40
pubmed: 30541036
J Chem Inf Model. 2018 May 29;58(5):1132-1140
pubmed: 29701973

Auteurs

Staffan Arvidsson McShane (S)

Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, 751 24 Uppsala, Sweden.

Ernst Ahlberg (E)

Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, 751 24 Uppsala, Sweden.
Stena Line Scandinavia AB, AI & Data, 405 19 Gothenburg, Sweden.
Predictive Compound ADME & Safety, Drug Safety & Metabolism, AstraZeneca IMED Biotech Unit, 431 50 Gothenburg, Sweden.

Tobias Noeske (T)

Imaging and Data Analytics, Clinical Pharmacology & Safety Sciences, R&D, AstraZeneca, 431 50 Gothenburg, Sweden.

Ola Spjuth (O)

Department of Pharmaceutical Biosciences and Science for Life Laboratory, Uppsala University, 751 24 Uppsala, Sweden.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Vancomycin-associated DRESS demonstrates delay in AST abnormalities.

Ahmed Hussein, Kateri L Schoettinger, Jourdan Hydol-Smith et al.
1.00
Humans Drug Hypersensitivity Syndrome Vancomycin Female Male
Humans Immune Checkpoint Inhibitors Lung Neoplasms Prognosis Inflammation
Humans Arthroplasty, Replacement, Hip Male Female Obesity, Morbid

Classifications MeSH